Europe Takes Leap Of Faith On AstraZeneca Vaccine
EU Confirms Approval, Excuses Lack Of Data In Older Groups
You may also be interested in...
Observational studies from the National Health Service show encouraging signs for the UK’s vaccination program.
This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the European Union, and updates on EU marketing authorization changes recommended by the CHMP.
Switzerland's medicines agency says it wants to see more data on AZD1222 before it can approve the vaccine. Also, a rolling review of Novavax's NVX-CoV2373, yet another COVID‑19 vaccine, is under way at the European Medicines Agency.